Sarcoma

Top Story

Seven updates in sarcoma treatment, research

July 21, 2016

An estimated 12,310 people in the United States will be diagnosed with soft tissue sarcomas this year, and 4,990 Americans will die of the disease, according to the American Cancer Society.

In conjunction with Sarcoma Awareness Month, HemOnc Today presents seven updates in sarcoma treatment and research.

In the Journals

Hispanic, younger children underrepresented in pediatric oncology trials

July 18, 2016
Underrepresentation of Hispanic patients and children aged 0 to 4 years occurred frequently in phase 1 trials, according to a meta-analysis of trials conducted by…

Alternative endpoints needed for osteosarcoma trials

July 15, 2016
Pediatric and young adult patients with recurrent or refractory osteosarcoma demonstrated uniformly poor EFS outcomes, according to a retrospective analysis of seven…
FDA News

FDA grants breakthrough therapy designation to LOXO-101 for solid tumors with NTRK gene fusions

July 14, 2016
The FDA granted breakthrough therapy designation to LOXO-101 for the treatment of unresectable or metastatic solid tumors with neurotrophic tyrosine receptor kinase gene…
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Video
Meeting News Coverage

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »

Seven updates in sarcoma treatment, research

July 21, 2016
An estimated 12,310 people in the United States will be diagnosed with soft tissue sarcomas this year, and 4,990 Americans will die of the disease…

In the Journals

Hispanic, younger children underrepresented in pediatric oncology trials

July 18, 2016
Underrepresentation of Hispanic patients and children aged 0 to 4 years occurred frequently in phase 1 trials, according to a meta-analysis of trials…

Alternative endpoints needed for osteosarcoma trials

July 15, 2016
Pediatric and young adult patients with recurrent or refractory osteosarcoma demonstrated uniformly poor EFS outcomes, according to a retrospective…

FDA News

FDA grants breakthrough therapy designation to LOXO-101 for solid tumors with NTRK gene fusions

July 14, 2016
The FDA granted breakthrough therapy designation to LOXO-101 for the treatment of unresectable or metastatic solid tumors with neurotrophic tyrosine…

Memorial Sloan Kettering program designed to meet needs of teens, young adults with cancer

July 13, 2016
Memorial Sloan Kettering Cancer Center launched a new initiative designed to help teens and young adults with cancer. The program offers services to…

FDA News

FDA grants TK216 orphan drug designation for Ewing sarcoma

July 13, 2016
The FDA today granted orphan drug designation to TK216 for the treatment of Ewing sarcoma, a rare pediatric cancer comprised of highly malignant…

In the Journals

Childhood cancer survivors at risk for endocrine disorders

July 12, 2016
The risk for endocrinopathies increased substantially over time among childhood cancer survivors, especially among those who received high-risk…

In the Journals

Cancer center advertising expenditures more than triple since 2005

July 11, 2016
Cancer treatment centers in the United States spent $173 million on advertising in the year 2014, according to a research letter published in JAMA

In the Journals

Older patients with soft tissue sarcoma benefit from adjuvant radiation

July 6, 2016
Adjuvant radiation appeared to benefit older patients with soft tissue sarcoma more than younger patients, according to retrospective study results…

FDA News

FDA approves Syndros for cancer, AIDS indications

July 5, 2016
The FDA approved dronabinol oral solution for the treatment of patients with cancer who experience chemotherapy-induced nausea and vomiting…

More Headlines »
morganatic-roan
morganatic-roan